Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No substantive content changes detected; the two screenshots show the same study details and page structure. Any observed differences appear to be visual/UI adjustments only.
    Difference
    0.1%
    Check dated 2026-04-02T15:23:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:24:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-12T01:15:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots.
    Difference
    0.1%
    Check dated 2026-03-05T00:26:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the lapse-in-government-funding notice was removed; no changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:12.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.